ANTIGENIC DETERMINANTS OF VARICELLA VIRUS
水痘病毒的抗原决定因素
基本信息
- 批准号:2386784
- 负责人:
- 金额:$ 32.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-09-01 至 2002-06-30
- 项目状态:已结题
- 来源:
- 关键词:antibody receptor antigen receptors confocal scanning microscopy gene mutation glycoproteins immunoelectron microscopy phosphorylation protein kinase protein purification protein transport site directed mutagenesis tissue /cell culture transfection varicella zoster virus virus antigen virus infection mechanism virus protein
项目摘要
DESCRIPTION (Adapted from Applicant's Abstract): Varicella-zoster virus
(VZV) is an evolutionarily ancient alphaherpesvirus with a 125 kbp genome.
VZV causes two diseases -- chickenpox and shingles; the latter disease is a
remarkable illustration of VZV neurotropism and reactivation from a
prolonged latency. The goal of the current proposal is an increased
understanding at a molecular level of the structure/function relationships
of the two unique short glycoproteins called gE and gI which form a Fc
receptor complex. The herpesviral gE/gI complex is known to be an important
determinant of viral egress and cell-to-cell spread, but the mechanisms are
not well understood. The Research Plan contains three Specific Aims. Aim 1
includes a characterization of the phosphorylation and sorting motifs in the
C-tail of gE. The glycoprotein receptor is modified by both serine and
tyrosine protein kinases; tyrosine phosphorylation occurs only on a dimeric
form of gE and has not been previously recognized. Phosphorylation will be
measured by both in vivo and in vitro protein kinase assays. The fact that
both serine and tyrosine phosphorylation motifs are common features of
several mammalian cell surface receptors supports the hypothesis that
VZVgE/gI form a pluripotential receptor complex. Aim 2 seeks through a
mutagenesis approach to further identify the serine protein kinase which
phosphorylates the unusual serine-proline-proline sequence in the C-tail of
gI, and also identify internalization motifs in proximity to the
phosphorylation site. In Aim 3, the interaction of the two components of
the gE/gI complex will be analyzed before and after mutagenesis in order to
determine the specific roles of each signaling motif on the function of the
entire complex. Endocytosis and recycling of the VZV gE/gI complex will be
investigated in detail. As a complementary strategy to transient
transfection assays, recombinant VZV gE-pseudorabies viruses will be
produced and evaluated in an animal model of neurotropism, and VZV mutants
with a gI null phenotype will be investigated by several imaging techniques,
including laser scanning confocal microscopy and electron microscopy with
immunolabeling. In summary, the phosphorylation modifications of VZV gE/gI
support an evolutionary link with other nonviral receptors and, at the same
time, suggest a role for phosphorylation-dephosphorylation events in
trafficking and endocytic pathways involved in viral egress and cell-to-cell
spread.
描述(改编自申请人摘要):水痘带状疱疹病毒
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles F. Grose其他文献
Charles F. Grose的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles F. Grose', 18)}}的其他基金
Wild-type allele found in varicella vaccine virus during severe herpes zoster
严重带状疱疹期间水痘疫苗病毒中发现野生型等位基因
- 批准号:
10038935 - 财政年份:2020
- 资助金额:
$ 32.71万 - 项目类别:
Autophagy and ER stress during varicella infection
水痘感染期间的自噬和内质网应激
- 批准号:
8427354 - 财政年份:2011
- 资助金额:
$ 32.71万 - 项目类别:
Autophagy and ER stress during varicella infection
水痘感染期间的自噬和内质网应激
- 批准号:
8232048 - 财政年份:2011
- 资助金额:
$ 32.71万 - 项目类别:
Autophagy and ER stress during varicella infection
水痘感染期间的自噬和内质网应激
- 批准号:
8803757 - 财政年份:2011
- 资助金额:
$ 32.71万 - 项目类别:
Autophagy and ER stress during varicella infection
水痘感染期间的自噬和内质网应激
- 批准号:
8101645 - 财政年份:2011
- 资助金额:
$ 32.71万 - 项目类别:
ACQUISITION OF HUMAN HERPES VIRUS-8 IN INFANCY
在婴儿期获得人类疱疹病毒 8
- 批准号:
7604837 - 财政年份:2007
- 资助金额:
$ 32.71万 - 项目类别:
IMMUNOSCANNING ELECTRON MICROSCOPY OF HERPES VIRUSES
疱疹病毒的免疫扫描电子显微镜
- 批准号:
6278480 - 财政年份:1998
- 资助金额:
$ 32.71万 - 项目类别:
IMMUNOSCANNING ELECTRON MICROSCOPY OF HERPES VIRUSES
疱疹病毒的免疫扫描电子显微镜
- 批准号:
6117285 - 财政年份:1998
- 资助金额:
$ 32.71万 - 项目类别:
DNA SEQUENCING--ITERATIVE STEPS BY PRODUCT REGENERATION
DNA 测序——产物再生的迭代步骤
- 批准号:
2889694 - 财政年份:1998
- 资助金额:
$ 32.71万 - 项目类别:
相似海外基金
Development of back bone vectors for chimeric antigen receptors against key molecules, CD47 and CD24, activating macrophages
开发针对关键分子 CD47 和 CD24 的嵌合抗原受体的骨干载体,激活巨噬细胞
- 批准号:
23K06728 - 财政年份:2023
- 资助金额:
$ 32.71万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAREER: Engineering next-generation chimeric antigen receptors for cancer immunotherapy using phospho-proteomics
职业:利用磷酸蛋白质组学设计用于癌症免疫治疗的下一代嵌合抗原受体
- 批准号:
2145853 - 财政年份:2022
- 资助金额:
$ 32.71万 - 项目类别:
Continuing Grant
Construction of a drug discovery platform utilizing antigen receptors that regulate the quality of cancer immunity
利用调节癌症免疫质量的抗原受体构建药物发现平台
- 批准号:
22K06603 - 财政年份:2022
- 资助金额:
$ 32.71万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Engineering synthetic adhesion receptors to enhance the sensitivity of therapeutic chimeric antigen receptors
工程合成粘附受体以增强治疗性嵌合抗原受体的敏感性
- 批准号:
MR/W031353/1 - 财政年份:2022
- 资助金额:
$ 32.71万 - 项目类别:
Research Grant
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
- 批准号:
10701754 - 财政年份:2022
- 资助金额:
$ 32.71万 - 项目类别:
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
- 批准号:
10557760 - 财政年份:2022
- 资助金额:
$ 32.71万 - 项目类别:
Chimeric antigen receptors on regulatory T cells as a treatment strategy in auto-immune diseases.
调节性 T 细胞上的嵌合抗原受体作为自身免疫性疾病的治疗策略。
- 批准号:
437200 - 财政年份:2020
- 资助金额:
$ 32.71万 - 项目类别:
Studentship Programs
Molecualr imaging for development of chimeric antigen receptors (CARs) resistant to T cell exhaustion
用于开发抗 T 细胞耗竭的嵌合抗原受体 (CAR) 的分子成像
- 批准号:
20H03536 - 财政年份:2020
- 资助金额:
$ 32.71万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
- 批准号:
10542442 - 财政年份:2020
- 资助金额:
$ 32.71万 - 项目类别:
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
- 批准号:
9922602 - 财政年份:2020
- 资助金额:
$ 32.71万 - 项目类别: